Allscripts Healthcare Solutions Company Profile (NASDAQ:MDRX)

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Application Software
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:MDRX
  • CUSIP: 01988P10
  • Web:
  • Market Cap: $2.07 billion
  • Outstanding Shares: 181,464,000
Average Prices:
  • 50 Day Moving Avg: $12.05
  • 200 Day Moving Avg: $11.59
  • 52 Week Range: $9.80 - $15.17
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 16.03
  • P/E Growth: 1.30
Sales & Book Value:
  • Annual Revenue: $1.62 billion
  • Price / Sales: 1.27
  • Book Value: $6.32 per share
  • Price / Book: 1.80
  • EBIDTA: $153.38 million
  • Net Margins: -0.14%
  • Return on Equity: 5.79%
  • Return on Assets: 2.50%
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 0.94%
  • Quick Ratio: 0.94%
  • Average Volume: 1.98 million shs.
  • Beta: 1.31
  • Short Ratio: 9.62

Frequently Asked Questions for Allscripts Healthcare Solutions (NASDAQ:MDRX)

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its earnings results on Thursday, May, 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. The company earned $415 million during the quarter, compared to analyst estimates of $415.20 million. Allscripts Healthcare Solutions had a negative net margin of 0.14% and a positive return on equity of 5.79%. The firm's quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.13 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When will Allscripts Healthcare Solutions make its next earnings announcement?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Allscripts Healthcare Solutions.

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2017?

19 analysts have issued 1 year price targets for Allscripts Healthcare Solutions' stock. Their forecasts range from $10.00 to $19.00. On average, they expect Allscripts Healthcare Solutions' stock price to reach $14.77 in the next year. View Analyst Ratings for Allscripts Healthcare Solutions.

What are analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

  • 1. Maxim Group analysts commented, "1Q17 bookings of $286M, up 13.5% y/y, were below our estimate of $302M and consensus of $298M." (5/5/2017)
  • 2. According to Zacks Investment Research, "Over the past three months, Allscripts has outperformed the broader industry trend in terms of price movement. However, an unfavorable estimate revision trend indicates looming concerns ahead. An intensifying market competition is a major dampener for Allscripts as large companies like Cerner, compete against Allscripts with a far simpler rationale for their products. Additionally, the Optum partnership is expected to have a cost-heavy impact on the revenues. Allscripts’ products have a long sales cycle which involves decision-making at different managerial levels. On a positive note, Allscripts has been reporting regular contract wins and addition of new domestic and international clients, which is expected to boost bookings in the coming quarters. Furthermore, the growing adoption of Allscripts’ products and services like the Sunrise platform, FollowMyHealth, Touchworks EHR, EPSi and dbMotion will drive market traction." (4/19/2017)
  • 3. Citigroup Inc analysts commented, "We are upgrading MDRX shares to Buy following its recent analyst day. Allscripts provided targets for 2018 - 2020 revenue growth of 6%-8% and EPS growth of 12%-15%, both of which are ahead of our forecasts but approximately in-line with the Street. Allscripts is beginning to show better results as non-recurring revenue has stabilized, recurring revenue grows faster, and the mix continues to shift to recurring revenue, with non EMR solutions seeing faster growth. We believe that if Allscripts can hit these targets investors could see a 20% return on the shares this year from current levels." (3/24/2017)
  • 4. Piper Jaffray Companies analysts commented, "We attended Allscripts' Investor Conference yesterday where management discussed its plan to deliver its FY17 guidance and long term growth targets. We believe 6-8% revenue growth and 12-15% EPS growth are achievable, provided the non-recurring revenue has surpassed its decline, and the Platform as a Service model continues to grow. We are tapering our FY18 EPS estimate to be in line with targets while maintaining our 20x EPS valuation, which brings our PT to $14 from $15. Reiterate Neutral." (3/22/2017)
  • 5. Cantor Fitzgerald analysts commented, "We reiterate our Neutral rating on Allscripts shares and our 12-month price target remains $13. On Tuesday, March 21, Allscripts hosted an analyst meeting. The company provided good insight into its growth strategy. In our view, the most important points were the strong improvement in client satisfaction scores, details on its CareInMotion population health applications and its payer initiatives. The company provided 3-year CAGR growth targets (2018 to 2020), which were in line with our long-term DCF model assumptions. While the company's fundamentals have improved over the last few years, the shares offer nominal upside to our price target of $13. Our rating remains at Neutral." (3/22/2017)

Who are some of Allscripts Healthcare Solutions' key competitors?

Who owns Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.11%), Iridian Asset Management LLC CT (7.17%), Blue Harbour Group L.P. (5.13%), Dimensional Fund Advisors LP (4.00%), Fiduciary Management Inc. WI (3.35%) and First Trust Advisors LP (3.24%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Who sold Allscripts Healthcare Solutions stock? Who is selling Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was sold by a variety of institutional investors in the last quarter, including Nomura Holdings Inc., First Eagle Investment Management LLC, Victory Capital Management Inc., Credit Suisse AG, Metropolitan Life Insurance Co. NY, Iridian Asset Management LLC CT, Menta Capital LLC and Cipher Capital LP. Company insiders that have sold Allscripts Healthcare Solutions stock in the last year include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Who bought Allscripts Healthcare Solutions stock? Who is buying Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Fiduciary Management Inc. WI, Dimensional Fund Advisors LP, Blue Jay Capital Management LLC, Vanguard Group Inc., Boston Partners, Cornerstone Capital Management Holdings LLC. and Neuberger Berman Group LLC. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Allscripts Healthcare Solutions stock cost?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $11.38.

Analyst Ratings

Consensus Ratings for Allscripts Healthcare Solutions (NASDAQ:MDRX) (?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $14.77 (29.76% upside)

Analysts' Ratings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017Cantor FitzgeraldReiterated RatingNeutral$13.00LowView Rating Details
5/15/2017Maxim GroupReiterated RatingBuy$16.00N/AView Rating Details
5/15/2017Bank of America CorpInitiated CoverageNeutral$14.00HighView Rating Details
3/27/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformHighView Rating Details
3/24/2017Citigroup IncUpgradeHold -> BuyLowView Rating Details
3/24/2017Deutsche Bank AGUpgradeHold -> Buy$12.50 -> $14.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesLower Price TargetNeutral$15.00 -> $14.00HighView Rating Details
3/22/2017Jefferies Group LLCReiterated RatingBuy$16.50HighView Rating Details
3/22/2017Cowen and CompanyBoost Price TargetMarket Perform$12.00 -> $13.00HighView Rating Details
2/17/2017Oppenheimer Holdings Inc.Reiterated RatingHoldN/AView Rating Details
2/13/2017Dougherty & CoUpgradeNeutral -> Buy$15.00N/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
12/13/2016Morgan StanleyDowngradeEqual Weight -> Underweight$15.00 -> $10.00N/AView Rating Details
10/30/2016JPMorgan Chase & Co.Initiated CoverageBuy$15.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
9/23/2016Leerink SwannReiterated RatingOutperform$17.00N/AView Rating Details
8/5/2016Goldman Sachs Group IncBoost Price TargetNeutral$14.00 -> $16.00N/AView Rating Details
7/9/2016Robert W. BairdReiterated RatingBuyN/AView Rating Details
5/22/2016KeyCorpReiterated RatingHoldN/AView Rating Details
2/24/2016SunTrust Banks, Inc.Lower Price TargetBuy$18.00 -> $15.00N/AView Rating Details
2/19/2016Barclays PLCLower Price TargetEqual Weight$15.00 -> $14.00N/AView Rating Details
2/19/2016Royal Bank of CanadaReiterated RatingOutperform$19.00 -> $17.00N/AView Rating Details
1/5/2016Topeka Capital MarketsBoost Price TargetHold$14.00 -> $15.00N/AView Rating Details
1/4/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
11/6/2015Evercore ISIBoost Price TargetHold$14.00 -> $15.00N/AView Rating Details
10/21/2015Avondale PartnersInitiated CoverageOutperform$19.00N/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Earnings History by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.15$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)
2017 EPS Consensus Estimate: $0.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.08$0.11$0.10
Q2 20174$0.10$0.12$0.11
Q3 20174$0.11$0.13$0.12
Q4 20173$0.12$0.15$0.14
(Data provided by Zacks Investment Research)


Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Insider Ownership Percentage: 0.75%
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.00View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.00View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.00View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.00View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.00View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.00View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Latest Headlines for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateHeadline logoAllscripts Healthcare Solutions (MDRX) Appoints Mara Aspinall to Director - - May 26 at 3:55 AM logoAllscripts names new director - May 24 at 6:31 PM logoAllscripts Healthcare Solutions Inc (MDRX) Given Consensus Recommendation of "Hold" by Analysts - May 22 at 6:20 PM logoResearch Analysts Offer Predictions for Allscripts Healthcare Solutions Inc's Q2 2017 Earnings (MDRX) - May 19 at 7:16 AM logoAllscripts Healthcare Solutions Inc (MDRX) President Sells $301,500.00 in Stock - May 18 at 10:23 PM logoAllscripts to present at upcoming investor events - May 17 at 9:19 AM logoAllscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner : MDRX-US : May 16, 2017 - May 16 at 10:33 AM logoAllscripts Healthcare Solutions Inc (MDRX) Given Neutral Rating at Cantor Fitzgerald - May 15 at 6:58 PM logoBank of America Corp Initiates Coverage on Allscripts Healthcare Solutions Inc (MDRX) - May 15 at 10:34 AM logoAllscripts Announces Leadership Change – Dennis Olis Named Interim Chief Financial Officer - May 12 at 7:07 PM logoCenters for Disease Control and Prevention selects Allscripts Technology to Support National Health Care Surveys - May 11 at 7:00 PM logoETFs with exposure to Allscripts Healthcare Solutions, Inc. : May 11, 2017 - May 11 at 7:00 PM logoZacks: Brokerages Expect Allscripts Healthcare Solutions Inc (MDRX) Will Post Earnings of $0.11 Per Share - May 11 at 8:42 AM logoAllscripts Healthcare Solutions, Inc. :MDRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 - May 9 at 11:51 AM logoMaxim Group Reaffirms "Buy" Rating for Allscripts Healthcare Solutions Inc (MDRX) - May 6 at 2:04 PM logoEdited Transcript of MDRX earnings conference call or presentation 4-May-17 8:30pm GMT - May 5 at 8:41 AM logoAllscripts Healthcare Solutions (MDRX) Q1 2017 Results - Earnings Call Transcript - May 4 at 11:35 PM logoAllscripts Healthcare Solutions Inc (MDRX) Announces Earnings Results, Hits Estimates - May 4 at 11:24 PM logoAllscripts Healthcare Solutions EPS and revenue in-line - May 4 at 6:35 PM logoEARNINGS SUMMARY: Details of Allscripts Healthcare Solutions Inc. Q1 Earnings Report - May 4 at 6:35 PM logoInvestor Network: Allscripts Healthcare Solutions, Inc. to Host Earnings Call - May 4 at 6:35 PM logoAllscripts announces first quarter 2017 results - May 4 at 6:35 PM logoAllscripts Healthcare Solutions, Inc. – Value Analysis (NASDAQ:MDRX) : May 4, 2017 - May 4 at 6:35 PM logoAllScripts reports 1Q loss - May 4 at 5:11 PM logoAllscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDRX-US : May 3, 2017 - May 3 at 5:34 PM logoAllscripts Healthcare Solutions Inc (MDRX) Scheduled to Post Earnings on Thursday - May 2 at 7:36 AM logoAllscripts Healthcare Solutions (MDRX) Earns Media Sentiment Rating of -0.15 - April 29 at 8:18 AM logoConcentra to launch Allscripts Practice Management for optimal efficiency and productivity - April 26 at 6:48 PM logoAllscripts Healthcare Solutions (MDRX) Getting Favorable News Coverage, Study Finds - April 26 at 4:24 PM logoAllscripts Healthcare Solutions Inc (MDRX) Receives Consensus Rating of "Buy" from Analysts - April 25 at 5:44 PM logoAllscripts eChart™ Courier service exchanges 10 million records - April 25 at 5:43 AM logoAllscripts Healthcare Solutions (MDRX) Receives Daily Media Impact Rating of 0.36 - April 23 at 4:21 PM logoAllscripts Professional EHR™ first health IT solution to deliver fully certified 2015 edition technology with Drummond Group LLC - April 20 at 6:35 PM logoAllscripts Healthcare Solutions Inc (MDRX) Expected to Announce Earnings of $0.09 Per Share - April 20 at 8:01 AM logoAllscripts Healthcare Solutions Inc (MDRX) Lifted to Hold at Zacks Investment Research - April 19 at 12:05 PM logoAllscripts Healthcare Solutions (MDRX) Given Media Impact Rating of 0.03 - April 17 at 9:52 PM logoAllscripts Healthcare Solutions Inc (MDRX) Stock Rating Reaffirmed by Canaccord Genuity - April 16 at 12:17 PM logoAllscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner : MDRX-US : April 14, 2017 - April 14 at 8:44 AM logoAllscripts Healthcare Solutions Breaks Below 200-Day Moving Average - Notable for MDRX - April 13 at 12:26 AM logoAllscripts announces dbMotion™ Solution now available through cloud on Microsoft Azure - April 11 at 11:20 AM logoAllscripts to release first quarter 2017 financial results May 4 - April 7 at 11:08 AM logoAllscripts Healthcare Solutions Inc (MDRX) Given Consensus Recommendation of "Hold" by Brokerages - March 31 at 2:07 PM logoAllscripts Healthcare upgraded by Wells Fargo - March 28 at 10:33 AM logoAllscripts Healthcare Solutions (MDRX) Jumps: Stock Rises 7% - March 28 at 10:33 AM logoJefferies Group LLC Reaffirms "Buy" Rating for Allscripts Healthcare Solutions Inc (MDRX) - March 28 at 8:11 AM logoAllscripts Has 20% Upside: Deutsche Bank Upgrades Stock To Buy - March 27 at 11:58 AM logoAllscripts Healthcare Solutions Inc (MDRX) Lifted to "Outperform" at Wells Fargo & Co - March 27 at 9:59 AM logoAllscripts Healthcare Solutions Inc (MDRX) SVP Brian Farley Sells 15,000 Shares - March 24 at 7:23 PM logoAllscripts Healthcare Solutions Inc (MDRX) Raised to "Buy" at Deutsche Bank AG - March 24 at 11:47 AM logoAllscripts Healthcare Solutions Inc (MDRX) Stock Rating Upgraded by Citigroup Inc - March 24 at 11:38 AM



Allscripts Healthcare Solutions (MDRX) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by Staff